September 4, 2025 · Form 4 insider transaction
Schwartz Jeffrey Lawrence bought 10,909 shares of Kestra Medical Technologies, Ltd., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.